Featured Research

from universities, journals, and other organizations

New technology for pharmaceutical drug development

Date:
June 23, 2010
Source:
University of Southampton
Summary:
A new technology platform for testing drugs will simplify the process and bring long-term benefits to the pharmaceutical industry.

A new technology platform for testing drugs will simplify the process and bring long-term benefits to the pharmaceutical industry.

Scientists at the University of Southampton and Birkbeck College, University of London are developing a platform consisting of an array of artificial cell membranes that will enable more efficient testing of potential new drugs.

The Bilayer Platform project, which begins this month, has been awarded 1.2 million from the Engineering and Physical Sciences Research Council to develop a new technology that uses artificial bilayer lipid membranes to evaluate the effectiveness of drugs on ion channels.

Professor Hywel Morgan and Dr Maurits de Planque at the University of Southampton's School of Electronics and Computer Science (ECS) will use the clean room technology in the new Mountbatten Building at the University of Southampton to build this novel platform for parallel on-chip electrophysiology. Each membrane patch will contain different ion channels.

According to Dr de Planque, ion channels play a pivotal role in a wide variety of physiological processes and diseases and are consequently of considerable interest to the pharmaceutical industry. It is for this reason the Southampton group has teamed up with the Birkbeck group, led by Professor Bonnie Ann Wallace, who are international experts in ion channel structure and function.

At the moment, pharmaceutical companies use electrodes to test entire cells, which can be expensive and involves testing a number of ion channels within the cell.

About 60 per cent of drugs work on membrane proteins (of which ion channels are a subclass) and the effectiveness of the drug is gauged by measuring activity in the ion channel as a result of administering the drug.

"By putting the ion channel into an artificial membrane, we only have one type of channel, no living cells and a relatively inexpensive method for testing for several of these types of channels at once," said Dr de Planque.

The project, which will take just over three years, will benefit public and private sector industries, as well as driving new research for the treatment of diseases such as chronic pain, epilepsy, and certain types of heart disease. The new technology platform will have many applications for drug discovery and testing long after the research period ends.


Story Source:

The above story is based on materials provided by University of Southampton. Note: Materials may be edited for content and length.


Cite This Page:

University of Southampton. "New technology for pharmaceutical drug development." ScienceDaily. ScienceDaily, 23 June 2010. <www.sciencedaily.com/releases/2010/06/100623085839.htm>.
University of Southampton. (2010, June 23). New technology for pharmaceutical drug development. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2010/06/100623085839.htm
University of Southampton. "New technology for pharmaceutical drug development." ScienceDaily. www.sciencedaily.com/releases/2010/06/100623085839.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins